Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Avita Medical, Inc. Common Stock (RCEL)

Surgical & Medical Instruments & Apparatus

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

28159 AVENUE STANFORD, SUITE 220
VALENCIA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/08/2012

Market Cap

235,466,655

Shares Outstanding

25,550,000

Weighted SO

25,550,694

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.5340

Last Div

0.0000

Range

7.51-18.93

Chg

-0.2500

Avg Vol

211777

Mkt Cap

235466655

Exch

NASDAQ

Country

US

Phone

661 367 9170

DCF Diff

20.9376

DCF

-10.4176

Div Yield

0.0000

P/S

4.7644

EV Multiple

-3.5187

P/FV

2.3491

Div Yield %

0.0000

P/E

-5.3603

PEG

-0.0536

Payout

0.0000

Current Ratio

6.2459

Quick Ratio

5.8761

Cash Ratio

4.2966

DSO

69.8051

DIO

273.4162

Op Cycle

343.2213

DPO

188.5866

CCC

154.6347

Gross Margin

0.9219

Op Margin

-0.9293

Pretax Margin

-0.8671

Net Margin

-0.8687

Eff Tax Rate

-0.0019

ROA

-0.3407

ROE

-0.4063

ROCE

-0.4268

NI/EBT

1.0019

EBT/EBIT

0.9330

EBIT/Rev

-0.9293

Debt Ratio

0.0299

D/E

0.0385

LT Debt/Cap

0.0285

Total Debt/Cap

0.0371

Int Coverage

0.0000

CF/Debt

-10.9154

Equity Multi

1.2864

Rec Turnover

5.2288

Pay Turnover

1.9355

Inv Turnover

1.3350

FA Turnover

7.1091

Asset Turnover

0.3922

OCF/Share

-1.6218

FCF/Share

-1.6869

Cash/Share

3.6816

OCF/Sales

-0.8335

FCF/OCF

1.0402

CF Coverage

-10.9154

ST Coverage

-45.5703

CapEx Coverage

-24.8971

Div&CapEx Cov

-24.8971

P/BV

2.3491

P/B

2.3491

P/S

4.7644

P/E

-5.3603

P/FCF

-5.4951

P/OCF

-5.5865

P/CF

-5.5865

PEG

-0.0536

P/S

4.7644

EV Multiple

-3.5187

P/FV

2.3491

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation